Cinacalcet for Hypercalcemia Caused by Pulmonary Squamous Cell Carcinoma Producing Parathyroid Hormone-Related Peptide
Background: Current treatments for hypercalcemia caused by lung cell carcinomas producing parathyroid hormone-related peptide (PTH-rp) have limited efficacy, probably because of their lack of effect on PTH-rp secretion. In this case study we explored the efficacy of the calcimimetic cinacalcet as su...
Main Authors: | Anneke Bech, Koen Smolders, Darryl Telting, Hans de Boer |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-01-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/335676 |
Similar Items
-
Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review
by: Michael Sheehan, et al.
Published: (2020-03-01) -
Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift
by: Sondra O’Callaghan, et al.
Published: (2021-02-01) -
Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries
by: Douglas S. Fuller, et al.
Published: (2019-05-01) -
Richter’s Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide
by: Naoki Watanabe, et al.
Published: (2017-01-01) -
The study of calcitriol, cinacalcet combined with nursing intervention effect of SHPT, calcium, phosphorus metabolism and parathyroid hormone on MHD patients
by: Le Chen, et al.
Published: (2017-06-01)